Review
doi: 10.3350/cmh.2013.19.4.325.
Epub 2013 Dec 28.
KASL clinical practice guidelines: management of nonalcoholic fatty liver disease
Collaborators
- PMID: 24459637
- PMCID: PMC3894432
- DOI: 10.3350/cmh.2013.19.4.325
Item in Clipboard
Review
KASL clinical practice guidelines: management of nonalcoholic fatty liver disease
Clin Mol Hepatol.
2013 Dec.
No abstract available
Keywords: Fatty liver; Guidelines; Hepatic steatosis; Steatohepatitis.
Conflict of interest statement
The authors have no conflicts to disclose.
Similar articles
-
Nonalcoholic Fatty Liver Disease: Common Questions and Answers on Diagnosis and Management.Am Fam Physician. 2020 Nov 15;102(10):603-612. Am Fam Physician. 2020. PMID: 33179890
-
Management of nonalcoholic fatty liver disease: a 60-year-old man with probable nonalcoholic fatty liver disease: weight reduction, liver biopsy, or both?JAMA. 2012 Aug 8;308(6):608-16. doi: 10.1001/jama.2012.8402. JAMA. 2012. PMID: 22760235
-
[The importance of AST / ALT rate in nonalcoholic steatohepatitis diagnosis].Arq Gastroenterol. 2002 Jan-Mar;39(1):22-6. doi: 10.1590/s0004-28032002000100005. Arq Gastroenterol. 2002. PMID: 12184161 Portuguese.
-
Nonalcoholic fatty liver disease: defining a common problem.Eur Rev Med Pharmacol Sci. 2005 Sep-Oct;9(5):253-9. Eur Rev Med Pharmacol Sci. 2005. PMID: 16231586 Review.
-
[Non-alcoholic fatty liver disease and steatohepatitis].Orv Hetil. 2013 Jul 21;154(29):1124-34. doi: 10.1556/OH.2013.29626. Orv Hetil. 2013. PMID: 23853345 Review. Hungarian.
Cited by
-
Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean Nationwide Study.Liver Cancer. 2023 Dec 22;13(4):426-437. doi: 10.1159/000535943. eCollection 2024 Aug. Liver Cancer. 2023. PMID: 39114758 Free PMC article.
-
New Insights into the Pathogenesis of Metabolic-Associated Fatty Liver Disease (MAFLD): Gut-Liver-Heart Crosstalk.Nutrients. 2023 Sep 14;15(18):3970. doi: 10.3390/nu15183970. Nutrients. 2023. PMID: 37764755 Free PMC article. Review.
-
Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis.Medicine (Baltimore). 2016 Jan;95(3):e2578. doi: 10.1097/MD.0000000000002578. Medicine (Baltimore). 2016. PMID: 26817915 Free PMC article.
-
Non-alcoholic Fatty Liver Disease: A Clinical Update.J Clin Transl Hepatol. 2017 Dec 28;5(4):384-393. doi: 10.14218/JCTH.2017.00013. Epub 2017 Jul 26. J Clin Transl Hepatol. 2017. PMID: 29226105 Free PMC article. Review.
-
NASH/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South Korea.Dig Dis. 2021;39(6):634-645. doi: 10.1159/000514953. Epub 2021 Feb 3. Dig Dis. 2021. PMID: 33535211 Free PMC article.
References
-
- Loria P, Adinolfi LE, Bellentani S, Bugianesi E, Grieco A, Fargion S, et al. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig Liver Dis. 2010;42:272–282. - PubMed
-
- Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55:2005–2023. - PubMed
-
- Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med. 2005;143:722–728. - PubMed
-
- Suzuki A, Angulo P, Lymp J, St Sauver J, Muto A, Okada T, et al. Chronological development of elevated aminotransferases in a nonalcoholic population. Hepatology. 2005;41:64–71. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
